Sunday, 9 June 2013

Keppra

Keppra

Keppra

Generic name/Active ingredient: Levetiracetam 250 mg or 500 mg
Trade name: Keppra
Dosage form: Tablet
Drug classification: Antiepileptics
Legal classification: POM
Company: GlaxoSmithKline
Commonly used for: Monotherapy in the treatment of partial onset seizures w/ or w/o secondary generalisation in patients ≥16 yr w/ newly diagnosed epilepsy. Adjunctive therapy in the treatment of partial onset seizures w/ or w/o secondary generalisation in adult & childn ≥4 yr w/ epilepsy; myoclonic seizures in adult & adolescent ≥12 yr w/ juvenile myoclonic epilepsy; primary generalised tonic-clonic seizures in adult & adolescent ≥12 yr w/ idiopathic generalised epilepsy